Genmark Diagnostics Inc (GNMK) Return on Assets ROA from the fourth quarter of 2020 to fourth quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Dec 31 2020 to Dec 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genmark Diagnostics Inc   (NASDAQ: GNMK)


Genmark Diagnostics Inc 's ROA from the fourth quarter of 2020 to the fourth quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Genmark Diagnostics Inc 's ROA in the fourth quarter of 2020?
Genmark Diagnostics Inc recorded a cumulative net loss of $-19 million during 12 months ending in the fourth quarter of 2020, resulting in a negative return on assets (ROA) of -10.01%.

However, within the Healthcare sector 315 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2020 from 3540 to 3728.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Total Assets Change 100.53 % 152.3 % 123.71 % 15.45 % 19.89 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -19 -25 -34 -42 -47
Return On Assets (TTM) -10.01 % -15.94 % -26.76 % -42.78 % -49.8 %
GNMK's Total Ranking # 3728 # 3540 # 3832 # 4139 # 4745
Total Assets (TTM) in million 224 215 195 112 111
Seq. Total Assets Change 4.17 % 10.04 % 74.76 % 0.11 % 31.06 %
Seq. Net Income Change - - - - -

GNMK's 5 Years Annual ROA >> Back to GNMK Management Effectiveness >> Compare GNMK ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 94
Sector # 316
Overall # 3626

Return On Assets Statistics
High Average Low
-10.01 %
-45.32 %
-70.45 %
(Dec 31 2020)   (Mar 31 2017)





Financial Statements
Genmark Diagnostics Inc 's Assets $ 224 million GNMK's Balance sheet
Genmark Diagnostics Inc 's Income $ -4 million Quarterly GNMK's Income Statement
GNMK's Income by Division See GNMK's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2017		 (Dec 31 2016)
FY 2015		 (Dec 31 2014)
FY 2014
Y / Y Total Assets Change 100.53 % 19.89 % 15.76 % -12.66 % -24.46 %
Total Assets in million 224 111 93 80 92
Y / Y Net Income Change - - - - -
Net Income in million -19 -47 -51 -51 -38
Annual Return On Assets -8.34 % -42.48 % -54.31 % -63 % -41.6 %

GNMK's 5 Years Annual ROA >> Back to GNMK Management Effectiveness >> Compare GNMK ROA to its Competitors



More Return On Assets Ratios
GNMK's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GNMK's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GNMK's Competitors
Subscribers only: Roa for Genmark Diagnostics Inc 's Suppliers
Subscribers only: Return On Assets for GNMK's Customers

You may also want to know
GNMK's Roi GNMK's Inventory Turnover Ratio GNMK's Growth Rates GNMK's Dividend Comparisons
GNMK's Profitability Ratios GNMK's Asset Turnover Ratio GNMK's Dividend Growth
GNMK's Roe GNMK's Valuation Ratios GNMK's Financial Strength Ratios GNMK's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:10+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.